Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.
U.S. government purchases additional 200 million doses of Moderna’s COVID-19 vaccine
June 16, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022